Global Non-invasive Continuous Glucose Monitor Market Growth 2026-2032

May 2026 | 107 pages | ID: G9719A2AF46AEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Non-invasive Continuous Glucose Monitor market size is predicted to grow from US$ 6883 million in 2025 to US$ 18846 million in 2032; it is expected to grow at a CAGR of 15.7% from 2026 to 2032.

Non-invasive Continuous Glucose Monitor is a glucose monitoring system that allows users to track glucose continuously without routine fingerstick blood sampling, avoiding the need to draw blood for day-to-day monitoring. It typically uses a wearable sensing component paired with durable electronics and software that collect signals frequently, estimate glucose levels and trends, and present results in a continuously updated view. These systems commonly provide alerts for rising or falling glucose and enable data sharing and longitudinal reporting, helping users and healthcare professionals manage therapy and reduce the risk of acute events and long-term complications. The unit price of a non-invasive continuous glucose monitor typically ranges from tens to hundreds of US dollars, with industry gross margins generally between 40% and 60%.

Upstream, the supply chain is anchored by specialized inputs for the disposable sensing element such as sensing chemistry and materials, electrodes and substrates, membranes, adhesives and skin-contact components, microelectronics, batteries, and sterile packaging, alongside software capabilities for signal processing, calibration, analytics, and cybersecurity. Manufacturers then execute precision sensor fabrication, calibration and quality control, assembly of wearable form factors, production of durable components such as transmitters or integrated electronics, and development of mobile apps and cloud services under medical-grade quality systems, often supported by contract manufacturers for electronics assembly, packaging, and scaling. Downstream, products are commercialized through clinician-led initiation and training, pharmacy and medical device distribution for replenishment of disposable components, and direct-to-consumer channels where permitted, while reimbursement rules and procurement mechanisms heavily influence adoption and pricing. Downstream value is increasingly shaped by onboarding and education, customer support and replacement logistics, caregiver and clinician data-sharing features, and partnerships that integrate monitoring into telehealth, remote patient monitoring, and insulin management ecosystems that drive adherence and lifetime value.

The non-invasive continuous glucose monitor market is evolving into a platform competition where long-term winners are determined less by the sensor patch itself and more by system reliability, alert performance, and ecosystem integration that supports real-world diabetes management. The key demand driver is the shift from episodic glucose checks to always-on monitoring that reduces uncertainty, supports behavioral change, and enables safer therapy decisions, especially for people who need tighter control or rapid feedback. Competitive advantage is increasingly built on the ability to deliver stable performance across daily conditions, minimize user burden through simple onboarding and durable wearability, and convert raw signals into trusted alerts and actionable insights. As the market expands beyond intensively managed users into broader populations, manufacturers face mounting expectations around clinical credibility, product quality, supply stability, and payer value demonstration, which collectively raise barriers to entry and favor scaled players with strong evidence generation and channel access.

LP Information, Inc. (LPI) ' newest research report, the “Non-invasive Continuous Glucose Monitor Industry Forecast” looks at past sales and reviews total world Non-invasive Continuous Glucose Monitor sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-invasive Continuous Glucose Monitor sales for 2026 through 2032. With Non-invasive Continuous Glucose Monitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Continuous Glucose Monitor industry.

This Insight Report provides a comprehensive analysis of the global Non-invasive Continuous Glucose Monitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive Continuous Glucose Monitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-invasive Continuous Glucose Monitor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Continuous Glucose Monitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Continuous Glucose Monitor.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Continuous Glucose Monitor market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Wristband Type
  • Patch Type
  • Others
Segmentation by Replacement Mechanism:
  • Replaceable Type
  • Long-term Retention Type
Segmentation by Intelligence:
  • Basic Type
  • Intelligent Type
Segmentation by Application:
  • Hospital
  • Clinic
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Roche
  • Abbott
  • Medtronic
  • Dexcom
  • I-SENS
  • 77 Elektronika
  • Senseonics
  • Yuwell
  • Sinocare
  • MicroTech Medical
  • POCTech
  • Medtrum Technologies
  • SIBIONICS
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-invasive Continuous Glucose Monitor market?
What factors are driving Non-invasive Continuous Glucose Monitor market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-invasive Continuous Glucose Monitor market opportunities vary by end market size?
How does Non-invasive Continuous Glucose Monitor break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Non-invasive Continuous Glucose Monitor Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Non-invasive Continuous Glucose Monitor by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Non-invasive Continuous Glucose Monitor by Country/Region, 2021, 2025 & 2032
2.2 Non-invasive Continuous Glucose Monitor Segment by Type
  2.2.1 Wristband Type
  2.2.2 Patch Type
  2.2.3 Others
  2.2.4 Non-invasive Continuous Glucose Monitor Sales by Type
    2.2.4.1 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2021-2026)
    2.2.4.2 Global Non-invasive Continuous Glucose Monitor Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global Non-invasive Continuous Glucose Monitor Sale Price by Type (2021-2026)
2.3 Non-invasive Continuous Glucose Monitor Segment by Replacement Mechanism
  2.3.1 Replaceable Type
  2.3.2 Long-term Retention Type
  2.3.3 Non-invasive Continuous Glucose Monitor Sales by Replacement Mechanism
    2.3.3.1 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Replacement Mechanism (2021-2026)
    2.3.3.2 Global Non-invasive Continuous Glucose Monitor Revenue and Market Share by Replacement Mechanism (2021-2026)
    2.3.3.3 Global Non-invasive Continuous Glucose Monitor Sale Price by Replacement Mechanism (2021-2026)
2.4 Non-invasive Continuous Glucose Monitor Segment by Intelligence
  2.4.1 Basic Type
  2.4.2 Intelligent Type
  2.4.3 Non-invasive Continuous Glucose Monitor Sales by Intelligence
    2.4.3.1 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Intelligence (2021-2026)
    2.4.3.2 Global Non-invasive Continuous Glucose Monitor Revenue and Market Share by Intelligence (2021-2026)
    2.4.3.3 Global Non-invasive Continuous Glucose Monitor Sale Price by Intelligence (2021-2026)
2.5 Non-invasive Continuous Glucose Monitor Segment by Application
  2.5.1 Hospital
  2.5.2 Clinic
  2.5.3 Other
  2.5.4 Non-invasive Continuous Glucose Monitor Sales by Application
    2.5.4.1 Global Non-invasive Continuous Glucose Monitor Sale Market Share by Application (2021-2026)
    2.5.4.2 Global Non-invasive Continuous Glucose Monitor Revenue and Market Share by Application (2021-2026)
    2.5.4.3 Global Non-invasive Continuous Glucose Monitor Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Non-invasive Continuous Glucose Monitor Breakdown Data by Company
  3.1.1 Global Non-invasive Continuous Glucose Monitor Annual Sales by Company (2021-2026)
  3.1.2 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Company (2021-2026)
3.2 Global Non-invasive Continuous Glucose Monitor Annual Revenue by Company (2021-2026)
  3.2.1 Global Non-invasive Continuous Glucose Monitor Revenue by Company (2021-2026)
  3.2.2 Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Company (2021-2026)
3.3 Global Non-invasive Continuous Glucose Monitor Sale Price by Company
3.4 Key Manufacturers Non-invasive Continuous Glucose Monitor Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Non-invasive Continuous Glucose Monitor Product Location Distribution
  3.4.2 Players Non-invasive Continuous Glucose Monitor Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NON-INVASIVE CONTINUOUS GLUCOSE MONITOR BY GEOGRAPHIC REGION

4.1 World Historic Non-invasive Continuous Glucose Monitor Market Size by Geographic Region (2021-2026)
  4.1.1 Global Non-invasive Continuous Glucose Monitor Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Non-invasive Continuous Glucose Monitor Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-invasive Continuous Glucose Monitor Market Size by Country/Region (2021-2026)
  4.2.1 Global Non-invasive Continuous Glucose Monitor Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Non-invasive Continuous Glucose Monitor Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-invasive Continuous Glucose Monitor Sales Growth
4.4 APAC Non-invasive Continuous Glucose Monitor Sales Growth
4.5 Europe Non-invasive Continuous Glucose Monitor Sales Growth
4.6 Middle East & Africa Non-invasive Continuous Glucose Monitor Sales Growth

5 AMERICAS

5.1 Americas Non-invasive Continuous Glucose Monitor Sales by Country
  5.1.1 Americas Non-invasive Continuous Glucose Monitor Sales by Country (2021-2026)
  5.1.2 Americas Non-invasive Continuous Glucose Monitor Revenue by Country (2021-2026)
5.2 Americas Non-invasive Continuous Glucose Monitor Sales by Type (2021-2026)
5.3 Americas Non-invasive Continuous Glucose Monitor Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Non-invasive Continuous Glucose Monitor Sales by Region
  6.1.1 APAC Non-invasive Continuous Glucose Monitor Sales by Region (2021-2026)
  6.1.2 APAC Non-invasive Continuous Glucose Monitor Revenue by Region (2021-2026)
6.2 APAC Non-invasive Continuous Glucose Monitor Sales by Type (2021-2026)
6.3 APAC Non-invasive Continuous Glucose Monitor Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Non-invasive Continuous Glucose Monitor by Country
  7.1.1 Europe Non-invasive Continuous Glucose Monitor Sales by Country (2021-2026)
  7.1.2 Europe Non-invasive Continuous Glucose Monitor Revenue by Country (2021-2026)
7.2 Europe Non-invasive Continuous Glucose Monitor Sales by Type (2021-2026)
7.3 Europe Non-invasive Continuous Glucose Monitor Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Non-invasive Continuous Glucose Monitor by Country
  8.1.1 Middle East & Africa Non-invasive Continuous Glucose Monitor Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Non-invasive Continuous Glucose Monitor Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-invasive Continuous Glucose Monitor Sales by Type (2021-2026)
8.3 Middle East & Africa Non-invasive Continuous Glucose Monitor Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-invasive Continuous Glucose Monitor
10.3 Manufacturing Process Analysis of Non-invasive Continuous Glucose Monitor
10.4 Industry Chain Structure of Non-invasive Continuous Glucose Monitor

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Non-invasive Continuous Glucose Monitor Distributors
11.3 Non-invasive Continuous Glucose Monitor Customer

12 WORLD FORECAST REVIEW FOR NON-INVASIVE CONTINUOUS GLUCOSE MONITOR BY GEOGRAPHIC REGION

12.1 Global Non-invasive Continuous Glucose Monitor Market Size Forecast by Region
  12.1.1 Global Non-invasive Continuous Glucose Monitor Forecast by Region (2027-2032)
  12.1.2 Global Non-invasive Continuous Glucose Monitor Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-invasive Continuous Glucose Monitor Forecast by Type (2027-2032)
12.7 Global Non-invasive Continuous Glucose Monitor Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Roche
  13.1.1 Roche Company Information
  13.1.2 Roche Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.1.3 Roche Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Roche Main Business Overview
  13.1.5 Roche Latest Developments
13.2 Abbott
  13.2.1 Abbott Company Information
  13.2.2 Abbott Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.2.3 Abbott Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Abbott Main Business Overview
  13.2.5 Abbott Latest Developments
13.3 Medtronic
  13.3.1 Medtronic Company Information
  13.3.2 Medtronic Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.3.3 Medtronic Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Medtronic Main Business Overview
  13.3.5 Medtronic Latest Developments
13.4 Dexcom
  13.4.1 Dexcom Company Information
  13.4.2 Dexcom Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.4.3 Dexcom Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Dexcom Main Business Overview
  13.4.5 Dexcom Latest Developments
13.5 I-SENS
  13.5.1 I-SENS Company Information
  13.5.2 I-SENS Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.5.3 I-SENS Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 I-SENS Main Business Overview
  13.5.5 I-SENS Latest Developments
13.6 77 Elektronika
  13.6.1 77 Elektronika Company Information
  13.6.2 77 Elektronika Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.6.3 77 Elektronika Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 77 Elektronika Main Business Overview
  13.6.5 77 Elektronika Latest Developments
13.7 Senseonics
  13.7.1 Senseonics Company Information
  13.7.2 Senseonics Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.7.3 Senseonics Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Senseonics Main Business Overview
  13.7.5 Senseonics Latest Developments
13.8 Yuwell
  13.8.1 Yuwell Company Information
  13.8.2 Yuwell Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.8.3 Yuwell Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Yuwell Main Business Overview
  13.8.5 Yuwell Latest Developments
13.9 Sinocare
  13.9.1 Sinocare Company Information
  13.9.2 Sinocare Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.9.3 Sinocare Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Sinocare Main Business Overview
  13.9.5 Sinocare Latest Developments
13.10 MicroTech Medical
  13.10.1 MicroTech Medical Company Information
  13.10.2 MicroTech Medical Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.10.3 MicroTech Medical Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 MicroTech Medical Main Business Overview
  13.10.5 MicroTech Medical Latest Developments
13.11 POCTech
  13.11.1 POCTech Company Information
  13.11.2 POCTech Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.11.3 POCTech Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 POCTech Main Business Overview
  13.11.5 POCTech Latest Developments
13.12 Medtrum Technologies
  13.12.1 Medtrum Technologies Company Information
  13.12.2 Medtrum Technologies Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.12.3 Medtrum Technologies Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Medtrum Technologies Main Business Overview
  13.12.5 Medtrum Technologies Latest Developments
13.13 SIBIONICS
  13.13.1 SIBIONICS Company Information
  13.13.2 SIBIONICS Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
  13.13.3 SIBIONICS Non-invasive Continuous Glucose Monitor Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 SIBIONICS Main Business Overview
  13.13.5 SIBIONICS Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Non-invasive Continuous Glucose Monitor Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-invasive Continuous Glucose Monitor Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Wristband Type
Table 4. Major Players of Patch Type
Table 5. Major Players of Others
Table 6. Global Non-invasive Continuous Glucose Monitor Sales by Type (2021-2026) & (K Units)
Table 7. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2021-2026)
Table 8. Global Non-invasive Continuous Glucose Monitor Revenue by Type (2021-2026) & ($ million)
Table 9. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Type (2021-2026)
Table 10. Global Non-invasive Continuous Glucose Monitor Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Replaceable Type
Table 12. Major Players of Long-term Retention Type
Table 13. Global Non-invasive Continuous Glucose Monitor Sales by Replacement Mechanism (2021-2026) & (K Units)
Table 14. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Replacement Mechanism (2021-2026)
Table 15. Global Non-invasive Continuous Glucose Monitor Revenue by Replacement Mechanism (2021-2026) & ($ million)
Table 16. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Replacement Mechanism (2021-2026)
Table 17. Global Non-invasive Continuous Glucose Monitor Sale Price by Replacement Mechanism (2021-2026) & (US$/Unit)
Table 18. Major Players of Basic Type
Table 19. Major Players of Intelligent Type
Table 20. Global Non-invasive Continuous Glucose Monitor Sales by Intelligence (2021-2026) & (K Units)
Table 21. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Intelligence (2021-2026)
Table 22. Global Non-invasive Continuous Glucose Monitor Revenue by Intelligence (2021-2026) & ($ million)
Table 23. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Intelligence (2021-2026)
Table 24. Global Non-invasive Continuous Glucose Monitor Sale Price by Intelligence (2021-2026) & (US$/Unit)
Table 25. Global Non-invasive Continuous Glucose Monitor Sale by Application (2021-2026) & (K Units)
Table 26. Global Non-invasive Continuous Glucose Monitor Sale Market Share by Application (2021-2026)
Table 27. Global Non-invasive Continuous Glucose Monitor Revenue by Application (2021-2026) & ($ million)
Table 28. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Application (2021-2026)
Table 29. Global Non-invasive Continuous Glucose Monitor Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Non-invasive Continuous Glucose Monitor Sales by Company (2021-2026) & (K Units)
Table 31. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Company (2021-2026)
Table 32. Global Non-invasive Continuous Glucose Monitor Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Company (2021-2026)
Table 34. Global Non-invasive Continuous Glucose Monitor Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Non-invasive Continuous Glucose Monitor Producing Area Distribution and Sales Area
Table 36. Players Non-invasive Continuous Glucose Monitor Products Offered
Table 37. Non-invasive Continuous Glucose Monitor Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Non-invasive Continuous Glucose Monitor Sales by Geographic Region (2021-2026) & (K Units)
Table 41. Global Non-invasive Continuous Glucose Monitor Sales Market Share Geographic Region (2021-2026)
Table 42. Global Non-invasive Continuous Glucose Monitor Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Non-invasive Continuous Glucose Monitor Sales by Country/Region (2021-2026) & (K Units)
Table 45. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Country/Region (2021-2026)
Table 46. Global Non-invasive Continuous Glucose Monitor Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Non-invasive Continuous Glucose Monitor Sales by Country (2021-2026) & (K Units)
Table 49. Americas Non-invasive Continuous Glucose Monitor Sales Market Share by Country (2021-2026)
Table 50. Americas Non-invasive Continuous Glucose Monitor Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Non-invasive Continuous Glucose Monitor Sales by Type (2021-2026) & (K Units)
Table 52. Americas Non-invasive Continuous Glucose Monitor Sales by Application (2021-2026) & (K Units)
Table 53. APAC Non-invasive Continuous Glucose Monitor Sales by Region (2021-2026) & (K Units)
Table 54. APAC Non-invasive Continuous Glucose Monitor Sales Market Share by Region (2021-2026)
Table 55. APAC Non-invasive Continuous Glucose Monitor Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Non-invasive Continuous Glucose Monitor Sales by Type (2021-2026) & (K Units)
Table 57. APAC Non-invasive Continuous Glucose Monitor Sales by Application (2021-2026) & (K Units)
Table 58. Europe Non-invasive Continuous Glucose Monitor Sales by Country (2021-2026) & (K Units)
Table 59. Europe Non-invasive Continuous Glucose Monitor Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Non-invasive Continuous Glucose Monitor Sales by Type (2021-2026) & (K Units)
Table 61. Europe Non-invasive Continuous Glucose Monitor Sales by Application (2021-2026) & (K Units)
Table 62. Middle East & Africa Non-invasive Continuous Glucose Monitor Sales by Country (2021-2026) & (K Units)
Table 63. Middle East & Africa Non-invasive Continuous Glucose Monitor Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Non-invasive Continuous Glucose Monitor Sales by Type (2021-2026) & (K Units)
Table 65. Middle East & Africa Non-invasive Continuous Glucose Monitor Sales by Application (2021-2026) & (K Units)
Table 66. Key Market Drivers & Growth Opportunities of Non-invasive Continuous Glucose Monitor
Table 67. Key Market Challenges & Risks of Non-invasive Continuous Glucose Monitor
Table 68. Key Industry Trends of Non-invasive Continuous Glucose Monitor
Table 69. Non-invasive Continuous Glucose Monitor Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Non-invasive Continuous Glucose Monitor Distributors List
Table 72. Non-invasive Continuous Glucose Monitor Customer List
Table 73. Global Non-invasive Continuous Glucose Monitor Sales Forecast by Region (2027-2032) & (K Units)
Table 74. Global Non-invasive Continuous Glucose Monitor Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Non-invasive Continuous Glucose Monitor Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Americas Non-invasive Continuous Glucose Monitor Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Non-invasive Continuous Glucose Monitor Sales Forecast by Region (2027-2032) & (K Units)
Table 78. APAC Non-invasive Continuous Glucose Monitor Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Non-invasive Continuous Glucose Monitor Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Europe Non-invasive Continuous Glucose Monitor Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Non-invasive Continuous Glucose Monitor Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Middle East & Africa Non-invasive Continuous Glucose Monitor Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Non-invasive Continuous Glucose Monitor Sales Forecast by Type (2027-2032) & (K Units)
Table 84. Global Non-invasive Continuous Glucose Monitor Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Non-invasive Continuous Glucose Monitor Sales Forecast by Application (2027-2032) & (K Units)
Table 86. Global Non-invasive Continuous Glucose Monitor Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Roche Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 89. Roche Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Roche Main Business
Table 91. Roche Latest Developments
Table 92. Abbott Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 94. Abbott Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Abbott Main Business
Table 96. Abbott Latest Developments
Table 97. Medtronic Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 98. Medtronic Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 99. Medtronic Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Medtronic Main Business
Table 101. Medtronic Latest Developments
Table 102. Dexcom Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 103. Dexcom Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 104. Dexcom Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Dexcom Main Business
Table 106. Dexcom Latest Developments
Table 107. I-SENS Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 108. I-SENS Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 109. I-SENS Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. I-SENS Main Business
Table 111. I-SENS Latest Developments
Table 112. 77 Elektronika Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 113. 77 Elektronika Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 114. 77 Elektronika Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. 77 Elektronika Main Business
Table 116. 77 Elektronika Latest Developments
Table 117. Senseonics Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 118. Senseonics Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 119. Senseonics Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Senseonics Main Business
Table 121. Senseonics Latest Developments
Table 122. Yuwell Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 123. Yuwell Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 124. Yuwell Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Yuwell Main Business
Table 126. Yuwell Latest Developments
Table 127. Sinocare Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 128. Sinocare Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 129. Sinocare Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Sinocare Main Business
Table 131. Sinocare Latest Developments
Table 132. MicroTech Medical Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 133. MicroTech Medical Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 134. MicroTech Medical Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. MicroTech Medical Main Business
Table 136. MicroTech Medical Latest Developments
Table 137. POCTech Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 138. POCTech Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 139. POCTech Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. POCTech Main Business
Table 141. POCTech Latest Developments
Table 142. Medtrum Technologies Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 143. Medtrum Technologies Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 144. Medtrum Technologies Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Medtrum Technologies Main Business
Table 146. Medtrum Technologies Latest Developments
Table 147. SIBIONICS Basic Information, Non-invasive Continuous Glucose Monitor Manufacturing Base, Sales Area and Its Competitors
Table 148. SIBIONICS Non-invasive Continuous Glucose Monitor Product Portfolios and Specifications
Table 149. SIBIONICS Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. SIBIONICS Main Business
Table 151. SIBIONICS Latest Developments

LIST OF FIGURES

Figure 1. Picture of Non-invasive Continuous Glucose Monitor
Figure 2. Non-invasive Continuous Glucose Monitor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-invasive Continuous Glucose Monitor Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Non-invasive Continuous Glucose Monitor Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-invasive Continuous Glucose Monitor Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-invasive Continuous Glucose Monitor Sales Market Share by Country/Region (2025)
Figure 10. Non-invasive Continuous Glucose Monitor Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Wristband Type
Figure 12. Product Picture of Patch Type
Figure 13. Product Picture of Others
Figure 14. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Type in 2026
Figure 15. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Replaceable Type
Figure 17. Product Picture of Long-term Retention Type
Figure 18. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Replacement Mechanism in 2026
Figure 19. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Replacement Mechanism (2021-2026)
Figure 20. Product Picture of Basic Type
Figure 21. Product Picture of Intelligent Type
Figure 22. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Intelligence in 2026
Figure 23. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Intelligence (2021-2026)
Figure 24. Non-invasive Continuous Glucose Monitor Consumed in Hospital
Figure 25. Global Non-invasive Continuous Glucose Monitor Market: Hospital (2021-2026) & (K Units)
Figure 26. Non-invasive Continuous Glucose Monitor Consumed in Clinic
Figure 27. Global Non-invasive Continuous Glucose Monitor Market: Clinic (2021-2026) & (K Units)
Figure 28. Non-invasive Continuous Glucose Monitor Consumed in Other
Figure 29. Global Non-invasive Continuous Glucose Monitor Market: Other (2021-2026) & (K Units)
Figure 30. Global Non-invasive Continuous Glucose Monitor Sale Market Share by Application (2025)
Figure 31. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Application in 2026
Figure 32. Non-invasive Continuous Glucose Monitor Sales by Company in 2026 (K Units)
Figure 33. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Company in 2026
Figure 34. Non-invasive Continuous Glucose Monitor Revenue by Company in 2026 ($ millions)
Figure 35. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Company in 2026
Figure 36. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Geographic Region in 2026
Figure 38. Americas Non-invasive Continuous Glucose Monitor Sales 2021-2026 (K Units)
Figure 39. Americas Non-invasive Continuous Glucose Monitor Revenue 2021-2026 ($ millions)
Figure 40. APAC Non-invasive Continuous Glucose Monitor Sales 2021-2026 (K Units)
Figure 41. APAC Non-invasive Continuous Glucose Monitor Revenue 2021-2026 ($ millions)
Figure 42. Europe Non-invasive Continuous Glucose Monitor Sales 2021-2026 (K Units)
Figure 43. Europe Non-invasive Continuous Glucose Monitor Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Non-invasive Continuous Glucose Monitor Sales 2021-2026 (K Units)
Figure 45. Middle East & Africa Non-invasive Continuous Glucose Monitor Revenue 2021-2026 ($ millions)
Figure 46. Americas Non-invasive Continuous Glucose Monitor Sales Market Share by Country in 2026
Figure 47. Americas Non-invasive Continuous Glucose Monitor Revenue Market Share by Country (2021-2026)
Figure 48. Americas Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2021-2026)
Figure 49. Americas Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2021-2026)
Figure 50. United States Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Non-invasive Continuous Glucose Monitor Sales Market Share by Region in 2026
Figure 55. APAC Non-invasive Continuous Glucose Monitor Revenue Market Share by Region (2021-2026)
Figure 56. APAC Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2021-2026)
Figure 57. APAC Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2021-2026)
Figure 58. China Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 62. India Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Non-invasive Continuous Glucose Monitor Sales Market Share by Country in 2026
Figure 66. Europe Non-invasive Continuous Glucose Monitor Revenue Market Share by Country (2021-2026)
Figure 67. Europe Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2021-2026)
Figure 68. Europe Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2021-2026)
Figure 69. Germany Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 70. France Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Non-invasive Continuous Glucose Monitor Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2021-2026)
Figure 77. Egypt Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Non-invasive Continuous Glucose Monitor Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Non-invasive Continuous Glucose Monitor in 2026
Figure 83. Manufacturing Process Analysis of Non-invasive Continuous Glucose Monitor
Figure 84. Industry Chain Structure of Non-invasive Continuous Glucose Monitor
Figure 85. Channels of Distribution
Figure 86. Global Non-invasive Continuous Glucose Monitor Sales Market Forecast by Region (2027-2032)
Figure 87. Global Non-invasive Continuous Glucose Monitor Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Non-invasive Continuous Glucose Monitor Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Non-invasive Continuous Glucose Monitor Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Non-invasive Continuous Glucose Monitor Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Non-invasive Continuous Glucose Monitor Revenue Market Share Forecast by Application (2027-2032)


More Publications